Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TMP/SMX Prophylaxis After AKI
NCT07224997Phase 2Not yet recruiting
- Sponsor
- Hospital Civil de Guadalajara
- Start
- Dec 2025
- Primary completion
- Jul 2027
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in bacterial infection comparing TMP/SMX with Placebo (2 arms). Primary endpoint: Any infection within 90 days after discharge. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
trimethoprim + sulfamethoxazole
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT07224997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07224997.